[ad_1] Recce Pharmaceuticals (ASX: RCE), a company developing a new class of synthetic antibiotics, is raising $11 million to boost its research program, bolster manufacturing capabilities and expand further into…
Tag: Recce
Recce Pharmaceuticals welcomes positive case studies and research data for R327 gel formulation; shares up
[ad_1] Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has welcomed positive clinical responses to a new gel formulation of its R327® drug candidate, covered by the Therapeutic Goods Administration’s (TGA) Special Access…